Tnf Alpha News Today

Short-term exposure to high outdoor temperatures may impair the immune system, rendering people more prone to infection and possibly accelerating heart disease progression.

Among the objectives of the study, which aims to enroll 8000 patients with HS, is to collect biospecimens from patients for translational studies.

This new route of administration is expected to become available during the fourth quarter of 2023.

The novel IL-1 inhibitor goflikicept is effective and relatively safe in idiopathic recurrent pericarditis.

A network meta-analysis ranked eight therapies for ulcerative colitis based on how fast they acted to relieve symptoms, with upadacitinib appearing most effective and ozanimod least effective.

In a large, retrospective cohort study, investigators found a slightly increased risk for MS in patients on TNF therapy, especially among those being treated for rheumatic disease.

Compared with conventional synthetic disease-modifying antirheumatic drugs (DMARDs), biologic and targeted synthetic DMARDs may lower dementia risk.

The highest prevalence of HS is among people in their 20s and 30s, so clinicians are likely to encounter female patients with HS who are either pregnant or actively thinking about getting pregnant.

Similar benefits were seen with low, moderate, and high statin doses, as well as in cases of both mild and severe acute pancreatitis.

Subquantifiable brodalumab levels were associated with a lack of response after 12 weeks, in the retrospective study.